Specification of retinal rod photoreceptors is determined by several different transcription factors that activate expression of rod-specific genes and repress expression of cone photoreceptor-specific genes. The mechanism by which this dual regulation occurs is unclear. We have found that Pias3, a transcriptional coregulator and E3 SUMO ligase that is selectively expressed in developing photoreceptors, promotes the differentiation of rod photoreceptors while preventing rods from adopting cone photoreceptor-like characteristics. Pias3 binds the photoreceptor-specific transcription factors Crx and Nr2e3 and is specifically targeted to the promoters of photoreceptor-specific genes. Pias3 SUMOylates Nr2e3, converting it into a potent repressor of cone-specific gene expression. Rod-and conespecific promoters are bound by hyperSUMOylated proteins in rod photoreceptors, and blocking SUMOylation in photoreceptors results in cells with morphological and molecular features of cones and an absence of rod-specific markers. Our data thus identify Pias3-mediated SUMOylation of photoreceptor-specific transcription factors as a key mechanism of rod specification.
INTRODUCTION
The vertebrate retina is a well-established system for studying neuronal specification. Rod photoreceptors are the best-studied retinal cell type at the molecular level. Several different transcription factors act to drive retinal precursors to a rod photoreceptor fate. Most of these genes are also expressed in mature rods and regulate both photoreceptor survival and terminal differentiation. Among these are the paired-type homeodomain genes Crx and Otx2, which are also expressed in cone photoreceptors, the Maftype bZip factor Nrl, and the nuclear hormone receptor Nr2e3 (Chen et al., 1997; Furukawa et al., 1997; Haider et al., 2000; Mears et al., 2001 ). Several of these factors not only promote rod differentiation but also prevent rods from acquiring characteristics of other retinal cells. Among these are Otx2, which prevents rods from adopting an amacrine fate (Nishida et al., 2003) , and Nrl and Nr2e3, which repress expression of conespecific genes in rods (Akhmedov et al., 2000; Chen et al., 2005; Mears et al., 2001; Peng et al., 2005) . Mutation of Nr2e3 in human patients leads to enhanced S-cone syndrome, and a spontaneous null mutation in Nr2e3 (the rd7/rd7 mouse line) results in rod photoreceptors that ectopically express S-cone markers (Haider et al., 2000; Jacobson et al., 2004) . It is poorly understood how these photoreceptor-enriched transcription factors act as both repressors and activators. In other systems, however, this dual regulation is achieved by the action of transcriptional coregulators. Most coregulators are broadly expressed, and their activity is thought to be regulated by posttranslational modification and protein-protein interaction (Lonard and O'Malley, 2006) .
Previously, we showed that Pias3 mRNA was selectively expressed in developing photoreceptors within the retina (Blackshaw et al., 2004) . Protein Inhibitor of Activated Stat3 (Pias3) was first identified as an inhibitor of Stat3-dependent transcription (Chung et al., 1997) . Later studies showed that Pias3 can act as both a transcriptional coactivator and corepressor and regulates the activity of many classes of transcription factors in nonneuronal cells, including Smads (Long et al., 2004) , nuclear hormone receptors (Junicho et al., 2000) , and Oct4 (Tolkunova et al., 2007) . Pias3 is also an E3 SUMO ligase, catalyzing covalent linkage of SUMO proteins, which are distant homologs of ubiquitin, to specific lysine residues on target proteins. SUMOylation, which in many ways mechanistically resembles ubiquitination, can reversibly modify the activity of a broad range of mostly nuclear proteins (Meulmeester and Melchior, 2008) . Pias3 is known to catalyze SUMOylation of a number of different transcription factors, many of which are also bound and regulated by Pias3 by SUMOylation-independent mechanisms (Kotaja et al., 2002; Schmidt and Muller, 2002) . The function of Pias3 in neural development has not been explored, however. Given the broad range of known Pias3 targets and its highly cell-specific expression pattern, we investigated whether Pias3 regulates rod photoreceptor development by regulating the activity of rod-specific transcription factors.
RESULTS

Pias3 Is Selectively Expressed in Developing Rod and Cone Photoreceptors
To determine if Pias3 protein was coexpressed with Pias3 mRNA in developing retina, we performed section immunostaining for Pias3. We confirmed the specificity of the antibody used by staining HEK293T cells transfected with a Pias3 overexpression construct (Figure S1A available online). We first observe weak expression of Pias3 in the outer region of the outer neuroblastic layer (ONBL) at postnatal day 0 (P0) ( Figure 1A ). Immunostaining with the rod precursor-specific transcription factor Nr2e3 revealed that Pias3 colocalized with Nr2e3. Coincident with previously reported in situ hybridization data, we observe that Pias3 protein expression increases in developing rods during the postnatal interval when rods are terminally specified. Protein expression peaks at P14 and then declines steadily. By P10, we also observe a subset of cells in the outer nuclear layer (ONL) that express Pias3 protein but not Nr2e3 (Figures 1A and 1B, arrowheads) . We performed double immunohistochemistry for TRb2, a transcription factor expressed in cone photoreceptors (Jones et al., 2007) , and observed expression of Pias3 in a subset of TRb2-positive cells (data not shown).
Pias3 Promotes Rod Differentiation and Represses Expression of Cone-Specific Genes
This selective expression of Pias3 in developing rods suggested that Pias3 regulates rod specification. We used in vivo electroporation of developing retina to determine the role of Pias3 in photoreceptor development (Matsuda and Cepko, 2004) . After overexpressing full-length Pias3 under the ubiquitous CAG promoter (CAG-Pias3, Figures 1D and 1H ) at P0, we observed by P14 a significant (p < 0.05) increase in the number of cells in the ONL with cell bodies in the inner outer nuclear layer (IONL) and rod-like morphology that labeled with an antirhodopsin antibody (Rho4D2), compared to cells electroporated with an empty vector control (CAG-GFP, Figures 1C and 1H) .
To quantify the composition of cells electroporated with fulllength Pias3, we performed dissociated cell immunocytochemistry with cell-type specific antibody markers for rods (Rho4D2), cones (cone transducin a subunit, Gnat2), rod bipolars (PKCa), amacrine cells (syntaxin), and Mü ller glia (glutamine synthetase, GS) (Matsuda and Cepko, 2004; Young et al., 2005) . Significantly more Rho4D2-positive cells (p < 0.005) were observed following electroporation with full-length Pias3 than with empty vector ( Figure 1I ). Fewer syntaxin and GS-positive cells were also seen (p < 0.05) ( Figure 1I ). Since rhodopsin is not expressed until roughly 6 days after rod precursors exit mitosis (Belliveau et al., 2000) , we tested if Pias3 overexpression altered the kinetics of rhodopsin expression ( Figure 1J ). No significant increase in the fraction of rhodopsin-positive cells was observed until P7, and we conclude that Pias3 does not induce precocious expression of rhodopsin. We observed that neither the fraction of proliferating cells (BrdU-positive cells pulsed at P0) nor of apoptotic cells (TUNEL-positive cells) changed significantly in electroporated cells following Pias3 overexpression at P7 and P10 (data not shown). These data suggest that Pias3 overexpression drives the electroporated retinal precursor cells to a rod cell fate at the expense of inner retinal cell types.
These data also suggest that Pias3 may directly enhance rhodopsin expression in transfected rod precursors after the first postnatal week. We tested the effects of Pias3 on expression of luciferase driven from a rhodopsin promoter construct in HEK293T cells. We found that Pias3 activates rhodopsin expression in a dose-dependent manner in the presence of the photoreceptor-specific transcription factors Crx, Nrl, and Nr2e3 ( Figure S2A ). Since Nr2e3 is also known to be a strong transcriptional repressor when bound to its own consensus binding site, we tested whether Pias3 would have any effect on Nr2e3-mediated transcriptional repression. We found that Pias3 also significantly enhanced Nr2e3-dependent repression ( Figure S2B ). Thus, Pias3 enhances both transcriptional activation and repression functions of Nr2e3, depending on the reporter tested and on other factors present.
We next tested the effect of reducing Pias3 expression in photoreceptor precursors. We used an shRNA expressed using the U6 promoter (U6-Pias3) that we confirmed to reduce Pias3 expression levels in retinal cells (Figures S1B and S1C) . We observe an increase in the localization of cells electroporated with the Pias3 shRNA construct (U6-Pias3) in the ONL at P14 when compared to a negative control shRNA (U6-control) construct ( Figures 1E and 1F ). Significantly more transfected cells (p < 0.005) were found in the outer portion of the outer nuclear layer (OONL) than in controls ( Figure 1H ), and these cells had large cell soma and short outer segments, a pattern characteristic of cone photoreceptors. Cells in the ONL electroporated with control shRNAs rarely expressed the cone-specific markers Gngt2 (cone transducin g subunit, Figure 1E ), Gnat2 (cone transducin a subunit, Figure 1K ), and S-cone opsin ( Figure 1M ). However, electroporation with Pias3-specific shRNA resulted in a dramatic increase (p < 0.005) in the fraction of cells expressing cone-specific markers ( Figures 1F and 1K ). Many photoreceptors electroporated with Pias3 shRNA expressed S-opsin, although the fraction expressing M-opsin was not increased ( Figure 1M ). We demonstrated that these shRNA effects are specific and can be rescued by shRNA-insensitive human PIAS3 ( Figure S1D ). We conclude that Pias3 is required to prevent developing rod photoreceptors from adopting a conelike morphology and gene expression pattern.
When several rod-specific transcription factors including Nrl and Nr2e3 are mutated, cone-specific genes are ectopically expressed in rod photoreceptors, with S-opsin, but not M-opsin, being upregulated in these rods Haider et al., 2000; Mears et al., 2001; Peng et al., 2005) . In photoreceptors of mice mutant for Nr2e3, however, expression of rod-specific genes is only slightly reduced, and hybrid cells showing both rod-and cone-like gene expression profiles are observed Corbo and Cepko, 2005) . We next tested if cells electroporated with Pias3 shRNA expressed both rod-specific and conespecific genes. Many rhodopsin-positive cells electroporated with Pias3 shRNA coexpressed Gnat2, though no cells expressing control shRNA did ( Figure 1L ). Quantifying these results ( Figure 1K expressed Gnat2, in comparison to only 4% in the control, roughly 30% of all electroporated cells expressed both Gnat2 and rhodopsin. The number of cells expressing only Gnat2 was not different between the two samples. Thus, we conclude that these cells, despite showing a cone-like morphology, are actually rods in which repression of cone-specific genes has been compromised-a phenotype like that seen with loss of Nr2e3 function.
We also measured expression of other cell-specific markers using dissociated cell immunohistochemistry in the same manner as for the overexpression studies shown in Figure 1I . We observe a slight reduction in the number of rhodopsin-positive cells following Pias3 knockdown ( Figure 1K ), along with a general reduction in the level of rhodopsin expression in each transfected cell (data not shown), consistent with a possible role for Pias3 in activation of rhodopsin expression ( Figure S2A ). We observe no changes in the fraction of PKCa or syntaxin-positive cells, but a significant decrease (p < 0.05) in the fraction of GS-positive Mü ller glia ( Figure 1K ), along with a reduction in the fraction of cells in the INL relative to controls (p < 0.05) ( Figure 1H ).
Pias3 Interacts with Nr2e3 and Crx In Vitro and In Vivo
Since Pias3 is known to interact with multiple different classes of transcription factors in nonneuronal cells, we tested whether Pias3 interacted with known photoreceptor-specific transcription factors. We performed coimmunoprecipitation using radiolabeled Crx in a Nr2e3-dependent manner ( Figure 2A , lanes 5 and 6) as previously reported (Peng et al., 2005) .
We next tested if Pias3 interacted with Nr2e3 and Crx in vivo. We performed co-IP using nuclear extracts of P10 retina from wild-type, Crx À/À , and rd7/rd7 (Nr2e3 null) strains. Immunoprecipitations were performed using antibodies against one of each of these three proteins and probed with all three antibodies. Immunoprecipitation using an anti-Crx antibody co-IPs Nr2e3, as previously reported Cheng et al., 2004) , as well as Pias3 from wildtype mice ( Figure 2B Figure 2B , lane 15), demonstrating the specificity of the anti-Pias3 antibody. Together, these data imply that Pias3 interacts directly with both Nr2e3 and Crx in vivo and in vitro and that this interaction is independent of either Nr2e3 or Crx. Given that these three proteins are coexpressed in developing photoreceptors and that Nr2e3 and Crx form a complex in vivo (Cheng et al., 2004; Peng et al., 2005) , we conclude that Nr2e3 and Crx are physiological targets of Pias3. We next tested whether the effects of Pias3 overexpression and knockdown were altered in rd7/rd7 animals. Overexpression of Pias3 in this background does not result in the increase in the cells in the inner outer nuclear layer (IONL), where the overwhelming majority of cells are rod photoreceptors ( Figure S3 ). Significantly fewer cells with cone-like morphology and cell bodies in the outer outer nuclear layer (OONL) (p < 0.005) are seen in rd7/rd7 retinas electroporated with Pias3 shRNA compared to wild-type retinas electroporated with the same construct, though more are seen than in retinas electroporated with control shRNA. Finally, all rd7/rd7 retinas showed more electroporated GS-positive INL cells with Mü ller glia-like morphology than in wild-type. Neither CAG-Pias3 nor U6-Pias3 constructs repressed Mü ller glial development in rd7/rd7 retinas, implying a role for Nr2e3 in repression of glial development.
Pias3 Is Selectively Present on the Promoters of Rod and Cone-Specific Genes that Are Known Targets of Crx and Nr2e3
Although the preceding data suggest that Pias3 interacts with Nr2e3 and Crx in vivo, we sought to confirm whether or not Pias3 is found together with Nr2e3 and Crx on the promoter regions of photoreceptor-specific genes. We first performed chromatin immunoprecipitation (ChIP) using antibodies to either Pias3 or Nr2e3 individually. We found that, as previously reported (Peng et al., 2005) antibodies to Nr2e3 selectively immunoprecipitate chromatin from promoters of rod and cone-specific genes such as rhodopsin, M-and S-cone opsin, and rod-specific phosphodiesterase b subunit, while promoters of genes selectively expressed in nonphotoreceptor cell types, such as bipolar cells and retinal ganglion cells, or of genes not expressed in the retina, such as albumin, are not immunoprecipitated with this antibody (Figure 3, lanes 1-3) . We find that antibodies to Pias3 show the same pattern of immunoprecipitation as Nr2e3 (Figure 3 , lanes 4-6). To determine whether Pias3 and Nr2e3 co-occupy the same promoters, we performed double ChIP (Figure 3 , lanes 7-12), and the same pattern of immunoprecipitation was observed. Similar results were obtained using quantitative single and double ChIP for rhodopsin, M-and S-opsin, and mGluR6 ( Figure S4A ). Promoter occupancy of each single ChIP experiment is $40%, the values of which are in line with other previously reported ChIP studies (Masui et al., 2007; Miotto and Struhl, 2008) . From this we conclude that Pias3 and Nr2e3 co-occupy the same sets of promoters in rod photoreceptor cells. However, this does not imply that Pias3 binding to these promoters requires both Nr2e3 and Crx. We performed ChIP assays for these same sequences from Crx À/À and rd7/rd7 mice and found that Pias3 is still immunoprecipitated from each photoreceptor promoter tested in either mutant background ( Figure S4B ), suggesting that neither protein is necessary to target Pias3 to these promoters.
Pias3 Catalyzes SUMOylation of Nr2e3, and SUMOylation-Deficient Mutants of Pias3 No Longer Effectively Promote Rod Differentiation
Since Pias3 can regulate target transcription factors both by direct protein-protein interaction and by its E3 SUMO ligase activity, we tested whether the E3 ligase activity is required for regulation of rod development by Pias3. Mutant forms of Pias3 tested included a double point mutation in the RING domain (C299S, H301A) that blocks the E3 SUMO ligase activity of Pias3 (Long et al., 2004) . Pias3 also contains an LXXLL coregulator recruitment motif in its N-terminal domain (Jang et al., 2004) , which can be inactivated by mutation of the terminal two leucines to alanines (Liu et al., 2001 ).
To characterize the interaction of Pias3 and Nr2e3, 35 S-labeleddeletion mutants of Pias3 were tested for interaction with fulllength Nr2e3 ( Figure S5 ). We found both the N-terminal domain and the RING domains of Pias3 are sufficient for interaction with Nr2e3 in vitro. Since SUMO1 was predicted to be the most abundant retinal SUMO isoform based on our previous SAGE study (Blackshaw et al., 2004) , we next determined if Pias3 can catalyze addition of SUMO1 to Nr2e3 and whether Pias3-Nr2e3 interaction was affected by the functional point mutations, first confirming the specificity of the SUMO1 antibody for immunoblot and immunoprecipitation ( Figure S6A ). HEK293T cells were cotransfected with plasmids containing wild-type mouse Nr2e3, and wild-type and mutant forms of both Pias3 and Flag-tagged SUMO1. We observe bands at $72 and $85 kD with both anti-Nr2e3 and anti-Flag, indicating that Flag-tagged SUMO1 is conjugated to Nr2e3 in the presence of wild-type Pias3 ( Figure 4A , lanes 1 and 9), corresponding to both di-and tri-SUMOylated forms of Nr2e3. The SUMOylation-deficient (DSUMO) RING domain mutant of Pias3, as expected, does not catalyze conjugation of Flag-SUMO1 to Nr2e3 to generate tri-SUMOylated Nr2e3 ( Figure 4A , lane 5), although some di-SUMOylated Nr2e3 is Single and double chromatin immunoprecipitation (ChIP) assays were performed using P14 mouse retinas. Results are shown as gel images of PCR products representing promoter sequences of the indicated candidate genes: IP, single or double immunoprecipitation with the indicated antibodies; -, nonspecific IgG controls (for double ChIP, the indicated specific antibody was used in the first IP, and a control IgG was used in the second IP); Inp, input without IP as a positive control for PCR. The candidate genes are shown based on the retinal cell type in which they are selectively expressed, with non Pias3/Nr2e3 target genes, which are not expressed in photoreceptor genes, shown in the three bottom lanes (BP, bipolar; GC, ganglion cells).
observed with the anti-Flag antibody in both the DSUMO sample and the sample lacking transfected Pias3. We interpret this data to suggest that other E3 SUMO ligases in the HEK293T cells used may SUMOylate Nr2e3. Unexpectedly, mutation of the LXXLL domain (LXXAA) also blocks the ability of Pias3 to catalyze SUMOylation of Nr2e3 ( Figure 4A, lane 3) , with no di-or triSUMOylated Nr2e3 seen in the presence of this mutant using that anti-Flag antibody ( Figure 4A, lane 11) . We speculate that this mutant may, through mechanisms that are unclear, have a dominant-negative effect on the activity of endogenous E3 SUMO ligases that generate the di-SUMOylated form of Nr2e3. Interaction of Nr2e3 and Pias3, however, was unaffected in any of the mutants tested ( Figure 4A, lanes 17-22) .
We next tested whether these mutant forms of Pias3 show altered ability to regulate rod photoreceptor development in vivo. We found that the morphology of cells electroporated with the DSUMO or LXXAA mutant forms of Pias3 were much like those electroporated with empty vector, but more GSpositive Mü ller glia were seen ( Figure 4B , white arrowheads). We also observed more cells expressing Gngt2 in the ONL (Figure 4B , upper panel, orange arrowheads), along with Gnat2 and S-cone opsin (data not shown). We find that, unlike wild-type Pias3, overexpression of both mutant forms of Pias3 does not result in additional cells in the ONL ( Figure 4C ). We next performed dissociated cell immunostaining to quantify changes in cell composition resulting from overexpression of mutant forms of Pias3. Neither mutant produced an increase in rhodopsinpositive cells, unlike wild-type Pias3 ( Figure 4D ). Moreover, a SUMOylase-deficient mutant of the human ortholog of Pias3, unlike wild-type human PIAS3, did not rescue the reduction in rhodopsin seen following Pias3 knockdown ( Figure S1D ). More electroporated cells expressed the cone marker Gnat2 for both mutants relative than in either wild-type Pias3 or in vector control (p < 0.05). We observed that a number of electroporated cells coexpressed both rhodopsin and Gnat2 ( Figure 4E ). This phenotype is reminiscent of that seen with Pias3 knockdown (Figure 1L ), although the increase in Gnat2-expressing cells is less dramatic. DSUMO mutants of Pias3 also failed to enhance Nr2e3-mediated transcriptional repression in HEK293T cells ( Figure S2B ). This suggests that these mutant forms of Pias3 act in vivo as partial dominant-negative mutations. Both mutant forms of Pias3 also lead to an increase in the number of Mü ller glia ( Figure 4B ). The mechanism of this effect is unclear.
Nr2e3 Is SUMOylated on Multiple Sites In Vitro and
In Vivo, and SUMOylation of Nr2e3 Is Necessary for Its Ability to Repress Cone-Specific Genes In Vivo Following up on the finding that Pias3 can SUMOylate Nr2e3 in vitro and in vivo, we sought to characterize the residues in Nr2e3 that can be SUMOylated. Analysis of mouse Nr2e3 sequence using SUMOplot (http://www.abgent.com/doc/ sumoplot) identified three high-probability sites for SUMOylation, at K178, K315 and K322 ( Figure 5A ), which are highly evolutionarily conserved. We tested whether these residues were necessary for SUMOylation of Nr2e3, constructing K to R point mutations for each of these sites individually and also a construct in which all three lysines had been mutated. We first tested these using transfected HEK293T cells and found that wild-type forms of Nr2e3 show two SUMOylated products, corresponding in size to potentially di-and tri-SUMOylated isoforms, in the presence of Pias3 ( Figure 5B, lane 1) . Triple-mutant forms of Nr2e3 are not SUMOylated ( Figure 5B, lane 9) . Finally, mutation of the K178 residue drastically affected the pattern and levels of SUMOylation of Nr2e3 ( Figure 5B, lane 3) . In this mutant isoform, the di-SUMOylated form of Nr2e3 was not observed in the presence of Pias3, although reduced levels of tri-SUMOylated Nr2e3 were still observed, presumably reflecting usage of a cryptic nonconsensus SUMOylation site. No change in SUMOylation levels or pattern was observed in either the K315R or K322R mutants ( Figure 5B, lanes 5 and 7) . Together, these results suggest that the observed di-SUMOylated form of Nr2e3 results from SUMOylation at K178 and at either K315 or K322.
We next investigated whether Nr2e3 is indeed SUMOylated in developing retina. We performed immunoprecipitation assays from both wild-type and rd7/rd7 retina using antibodies directed against both Nr2e3 and SUMO1. Immunoprecipitation with antiNr2e3 followed by immunoblotting with anti-SUMO1 detects a band at $70 kD that corresponds to the size of di-SUMOylated Nr2e3 observed in transfected HEK293T cells ( Figure 5C , lane 1). This band is not detectable in retinas of rd7/rd7 mice with either anti-SUMO1 ( Figure 5C , lane 2) or with anti-Nr2e3 ( Figure 5C , lane 7). The anti-SUMO1 antibody recognizes a protein that runs at roughly the same size as SUMOylated Nr2e3 in the input lane ( Figure 5C , lane 5, asterisk). However, since this band is not immunoprecipitated with anti-Nr2e3 and is also present in retinas from rd7/rd7 animals, we conclude that it does not represent SUMOylated Nr2e3 but rather another SUMOylated protein that coincidentally has a similar electrophoretic mobility.
To determine whether SUMOylation of Nr2e3 is essential for its function in vivo, we tested if overexpression of SUMOylationdeficient mutants of Nr2e3 could rescue defects observed in rd7/rd7 animals. We electroporated wild-type Nr2e3 and SUMOylation-deficient mutants of Nr2e3, along with empty vector controls, into P0 rd7/rd7 animals and examined the phenotypes at P14. In retinas electroporated with empty vector, we observe many electroporated photoreceptors that are double labeled with S-opsin, consistent with previously published data ( Figure 5D ) Peng et al., 2005) . We also observe more electroporated cells with Mü ller glial morphology that express GS than in wild-type animals. This may represent gliosis associated with the retinal rosettes seen in rd7/rd7 animals or else may represent an unreported function of Nr2e3 in repressing Mü ller glial differentiation. Electroporation of wild-type Nr2e3 results in a reduced number of cells expressing S-cone opsin ( Figure 5D , white arrowheads), consistent with previous studies demonstrating a role of Nr2e3 in directly repressing S-cone opsin expression (Peng et al., 2005) along with a substantial reduction in the number of Mü ller glia ( Figure 5D , red arrowheads) and other cells of the INL (Figure 5E ), indicating that wild-type Nr2e3 partially rescues the phenotype observed in rd7/rd7 animals. Electroporation of single SUMOylation-deficient mutants reveals that the K178R mutant does not efficiently rescue the rd7/rd7 phenotype, as indicated by the large number of S-cone opsin positive photoreceptors and the increase in the number of cells with cone-like morphology in the outer ONL (p < 0.005) ( Figures  5D and 5E ). In fact, the number of cells with cone-like morphology (though not the number of cells expressing S-opsin) is greater in the K178R mutant than in vector control alone, suggesting that overexpression of K178R may disrupt the function of endogenous photoreceptor-specific transcription factors such as Crx and Nrl that are known to interact with Nr2e3 Cheng et al., 2004) . However, K315R and K322R mutants rescued both the morphology and S-opsin expression phenotypes at a level roughly equal to wild-type Nr2e3 ( Figures 5D  and 5E ). These in vivo data are consistent with the pattern of SUMOylation observed in transfected cells ( Figure 5B ). Finally, we observed that the triple-mutant form of Nr2e3 not only did not rescue the rd7/rd7 phenotype in electroporated photoreceptors but appeared to enhance the mutant phenotype, generating a significantly higher fraction of cells located in the outer ONL compared to vector control and many more photoreceptors expressing S-cone opsin (p < 0.005) (Figures 5D and 5E ). Similar results were observed in wild-type retinas electroporated with the triple-mutant form of Nr2e3, suggesting that mutant Nr2e3 may interfere with the activity of wild-type Nr2e3 or associated proteins such as Nrl (Cheng et al., 2004) . Triple-mutant forms of Nr2e3 also failed to show any increase in transcriptional repression of HEK293T cells in the presence of Pias3, while SUMO1-Nr2e3 fusion proteins repressed transcription more efficiently than wild-type Nr2e3 ( Figure S2B ). Moreover, SUMO1-Nr2e3 fusions rescued the phenotype seen in rd7/rd7 cells as efficiently as wild-type Nr2e3 (Figures 5D and 5E ). These data indicate that Pias3-dependent SUMOylation is needed for maximal repression of cone-specific transcription by Nr2e3.
The Promoters of Rod-and Cone-Specific Genes Are HyperSUMOylated, and SUMOylation Is Essential for Normal Photoreceptor Differentiation To see if SUMOylation is associated with the promoters of photoreceptor-specific genes that are bound by Nr2e3, we performed single and double ChIP for Nr2e3 and SUMO1. Both single and double ChIP revealed similar results. We observed that the promoters of both rod-and cone-specific genes are hyperSUMOylated relative to the promoters of genes selectively expressed in nonphotoreceptor cell types, or not expressed in the retina (Figures 6A and S6B ). Since we observe hyperSUMOylation of rod and cone-specific promoters following initial immunoprecipitation with Nr2e3, this implies that rod-and conespecific promoters are hyperSUMOylated in rod photoreceptors, implying that SUMOylation is associated with both transcriptionally active and inactive photoreceptor-specific promoters in these cells.
We next tested the effects of global inhibition of SUMOylation on photoreceptor development. The adenoviral protein Gam1 has been identified as a dominant-negative inhibitor of SUMO E1 ligase (Boggio et al., 2004) . Since all forms of SUMOylation use the same E1 ligase, overexpression of Gam1 abolishes all cellular SUMOylation. Overexpression of Gam1 in developing retina from P0 results in photoreceptors adopting a cone-like morphology and ectopically expressing Gngt2 ( Figure 6C ). We also observed more S-cone opsin positive cells compared to vector control (p < 0.05) ( Figures 6F and 6H ). This suggests that loss of SUMOylation results in a failure to repress conespecific gene expression in rods, as is seen with knockdown of Pias3 and overexpression of SUMOylation-deficient mutants of Nr2e3. However, these cells also lack detectable rhodopsin expression ( Figure 6E ). We thus conclude that loss of SUMOylation not only results in ectopic expression of S-cone-specific genes in rods but is required for normal expression of rhodopsin.
DISCUSSION
Pias3 Promotes Rod Development, Repressing Expression of Cone-Specific Genes in Rods
Pias3 protein is first weakly detectable in developing photoreceptors at birth, with expression peaking in the postnatal week. This spatial and temporal expression pattern corresponds almost precisely with that of the known photoreceptor-specific transcription factors Crx, Nrl, and Nr2e3 and closely matches the previously published Pias3 mRNA expression pattern (Blackshaw et al., 2004) . Since Pias3 can regulate many different classes of transcription factors, we hypothesized that it might act in vivo to regulate the function of multiple photoreceptorspecific transcription factors. We tested this hypothesis using overexpression and knockdown of Pias3 and observed that Pias3 overexpression led to an increased number of rhodopsin-positive, rod-like cells in the ONL and fewer inner retinal cells relative to controls, while Pias3 knockdown generates photoreceptors with cone-like morphology and molecular features but which still express rod-specific genes. Curiously, both overexpression and knockdown of Pias3 also lead to a reduced number of Mü ller glial cells, an effect that is dependent on the presence of Nr2e3. This may imply that an intermediate level of Pias3 expression in photoreceptor precursor cells may permit some to adopt a glial fate, while high or low levels of Pias3 may commit these cells to a photoreceptor fate. Alternatively, Pias3 overexpression might mimic loss of function by titrating proteins that direct glial specification away from their endogenous targets.
Pias3 Interacts with Photoreceptor-Specific Transcription Factors and Regulates Expression of Photoreceptor-Specific Genes
The increase in rod photoreceptor number seen following Pias3 overexpression is like that seen following Crx overexpression (Furukawa et al., 1997) . Likewise, the ectopic expression of S-cone-specific transcripts seen in rods where Pias3 expression has been knocked down resembles that seen in mice mutant for Nr2e3. We found that Pias3 interacts with both these proteins in vivo and is selectively targeted to the promoters of photoreceptor-specific genes. It is likely that Crx and Nr2e3, however, do not represent the full set of Pias3 targets in rod photoreceptors. Crx and Nr2e3 can be found as part of a multiprotein complex along with Nrl,, Crx, and the nuclear hormone receptor Nr1d1 in vivo Cheng et al., 2004) , We have observed that Pias3 can be immunoprecipitated from postnatal retina as part of a complex containing both Nrl and Otx2, and Pias3 can directly bind both these proteins in vitro (data not shown). It is thus possible that Pias3 may in part function as a bridging protein to facilitate the assembly of this transcription factor complex on photoreceptor promoters.
Pias3-Mediated SUMOylation of Nr2e3 Is Required for Repression of Cone-Specific Genes in Rods
Nr2e3, which is bound to the promoters of both rod-and conespecific genes in developing rod photoreceptors, is a transcriptional activator on the promoters of rod-specific genes but represses the expression of cone photoreceptor-specific genes in vivo. Since other identified photoreceptor-specific transcription factors such as Crx and Nrl are also present at each of these promoters (Peng et al., 2005) , the mechanism of this divergent transcriptional regulation has been a mystery. We provide evidence that suggests that this may be mediated by selective SUMOylation of Nr2e3 by Pias3. We demonstrate that not only does Pias3 directly SUMOylate Nr2e3 and that Nr2e3 is SUMOylated in developing retina but that SUMOylation-deficient mutants of Nr2e3 fail to rescue the mutant phenotype in rd7/ rd7 mice. Pias3 enhances Nr2e3-mediated transcriptional repression in heterologous cells, and this effect is dependent on the presence of both the SUMO ligase of Pias3 and the SUMOylated lysine resides in Nr2e3. SUMOylation of Nr2e3 appears to be critical for repression of cone-specific genes, but it does not seem to be the only target of Pias3 in this pathway. Though Pias3 knockdown results in a less dramatic increase in cells with cone-like morphology and gene expression pattern in rd7/rd7 animals than in wild-type, we still observe an increase in cone-like cells over controls ( Figure S3B ). This suggests that other transcription factors that repress conespecific gene expression, among them Nrl, may also be physiological targets of Pias3. While loss of function of Pias3 leads to an upregulation of S-opsin but M-opsin expression in rods, essentially phenocopying the rd7/rd7 in this respect Corbo and Cepko, 2005; Peng et al., 2005) , Pias3 protein is found associated with the promoters of both S-and M-opsin genes in rod photoreceptors, along with Nr2e3 ( Figure 3) . The reason why M-opsin is not upregulated following loss of function of either Pias3 or Nr2e3 is still unclear, although the presence of an additional cone-specific factor, such as the thyroid hormone receptor TRb2 (Ng et al., 2001) , may be necessary to allow expression of M-opsin.
SUMOylation of the Promoters of PhotoreceptorSpecific Genes Coordinates Normal Photoreceptor Development Many nuclear proteins are SUMOylated in vivo. SUMOylation has been traditionally thought of a signal for transcriptional repression and chromatin silencing (Gill, 2005; Girdwood et al., 2004) . It has been proposed that SUMOylation may serve as a general signal for recruitment of histone deacetylases that trigger transcriptional silencing, or else may target SUMOylated DNA-protein complexes to regions of the nucleus associated with transcriptional silencing. Recent data, however, have suggested that SUMOylation of transcription factors may also lead to transcriptional activation (Lyst and Stancheva, 2007) , though the mechanism by which this occurs is unclear. Our data suggests that hyperSUMOylation is a general property of both rod and cone-specific promoters in rod photoreceptor cells, but is not detectable in rods on promoters of genes that are selectively expressed in nonphotoreceptor cells of the retina. We hypothesize that this reflects the modification of substrate proteins, among them Nr2e3, by Pias3 targeted to these promoters. Though we have shown that SUMOylated Nr2e3 represses cone-specific gene expression in rods, it is not clear if this represents the only SUMOylated protein found on the promoters of cone-specific genes ( Figure 6A ). Other than Nr2e3 itself, the identity of these SUMOylated proteins is unclear. Phosducin is the only SUMOylated mammalian photoreceptor-specific protein identified to date (Klenk et al., 2006) . Phosducin is localized mainly in photoreceptor outer segments, and SUMOylation alters its stability and interaction with the b and g subunits of transducin. It has been suggested that phosducin may also interact with Crx to regulate transcription of photoreceptorspecific genes (Zhu and Craft, 2000) . If nuclear phosducin is indeed associated with photoreceptor promoters, it would represent a possible substrate for Pias3-dependent modification. One additional potential retinal target is phosphorylated Stat3, which was the first identified biochemical target of Pias3 (Chung et al., 1997) , and can both inhibit rod photoreceptor development and promote Mü ller glial differentiation. However, the expression patterns of Pias3 protein and pStat3 overlap little in developing retina, with pStat3 expression undetectable in photoreceptor precursors by the time Pias3 expression is seen (Goureau et al., 2004; Ozawa et al., 2004; Zhang et al., 2004) , and it is questionable whether pStat3 is a major retinal target of Pias3.
The function of SUMOylation in neural development is obscure. One recent study has demonstrated that Sox10 activity during neural crest development is modified by SUMOylation (Taylor and Labonne, 2005) , while another has shown that SUMOylation of Mef2C by Pias1 can modulate dendrite development in cerebellar granule neurons (Shalizi et al., 2006 (Shalizi et al., , 2007 . Here, our data directly link SUMOylation to specification of a specific subtype of neuron.
Pias3 as Central Coordinator of Rod Photoreceptor Development
Attention has historically focused on DNA-binding transcription factors as the key determinants of regional patterning and cellfate specification. Pias3 is one of a handful of transcriptional coregulators with highly cell-or tissue-specific expression patterns that have been identified. A few of these coregulators have been shown to play a critical role in developmental processes, including Dach1 in organogenesis (Li et al., 2003) , and myocardin in smooth and cardiac muscle development (Wang et al., , 2003 . Pias3 represents the first protein in this category to play a clear role in neuronal cell-fate specification.
Based on these data, we conclude that Pias3 plays a multifunctional role in the regulation of photoreceptor development. Our findings suggest that Pias3 acts to promote rod photoreceptor development by modulating the activity of photoreceptor proteins, among them Nr2e3 and Crx (Figure 7) . Though expression of rod-specific genes is dependent on Pias3-mediated SUMOylation, it is not yet clear which proteins must be SUMOylated for this effect. Whatever the relevant SUMOylated factors are for regulating expression of rod-specific genes, it is unlikely that these include Nr2e3, as both the DSUMO mutant of Pias3 and the triple SUMOylation-deficient mutant of Nr2e3 activate transcription of rhodopsin in heterologous cells equally as well as the wild-type forms of both proteins ( Figure S2A ). We interpret our results to show that Pias3 binds Nr2e3 when it is bound to the promoters of cone-specific genes and also SUMOylates it, converting it to a strong transcriptional repressor and ensuring that only rod-specific genes are expressed in rod photoreceptors. Pias3 thus acts to both enhance rod-promoting and confer cone-repressing functions on its target proteins, though the relevant targets of Pias3-dependent SUMOylation in activation of rod-specific genes remain to be determined ( Figure 7 ). It is likely that the targets of Pias3 are not limited to Crx and Nr2e3, and further studies will clarify its mechanism of action.
EXPERIMENTAL PROCEDURES Animals
Timed pregnant CD1 mice were purchased from Charles River Breeding Laboratories. C57BL/6J and rd7/rd7 mice were purchased from the Jackson Laboratory. A Crx À/À mouse was provided by C. Cepko at Harvard Medical School.
All experimental procedures were preapproved by JHMI animal care and the Institutional Animal Care and Use Committee of Washington University School of Medicine, and conformed to the guidelines of the Association for Research in Vision and Ophthalmology for the use of live animals in vision research.
DNA Constructs
Details for all cDNA constructs used in this study are shown in Table S1 .
In Vivo Electroporation
In vivo electroporation were performed at P0 as previously described (Matsuda and Cepko, 2004) . Approximately 0.3 ml of DNA solutions (5 mg/ml) was injected into the subretinal space of P0 mouse pups, and square electric pulses (100 V; five 50 ms pulses with 950 ms intervals) were applied with tweezer-type electrodes (BTX, model 522). pCAGIG vector was coelectroporated (1 mg/ml) with both shRNA constructs to allow for visualization of transfected cells. The electroporated retinas were harvested at P4, P7, and P14 for immunohistochemistry.
Immunohistochemistry
For section immunohistochemistry, retinas were fixed with 4% paraformaldehyde in PB for $1 hr at room temperature, cryoprotected in PBS containing 15% sucrose overnight at 4 C, embedded in OCT compound (Sakura), and cryosectioned (20 mm). For dissociated cell immunohistochemistry, retinas were separated into single cells as described (Matsuda and Cepko, 2004) and plated on poly-D-lysine-coated glass slides and fixed for 5 min at room temperature. Images were taken on a fluorescence light microscope (Axioskop2, Carl Zeiss) or a scanning confocal microscope (Meta 510, Carl Zeiss). Sources and dilutions of all antibodies used are listed in Table S2 . A minimum of three retinas from two different litters were examined for each construct tested for section immunohistochemical analysis. For dissociated cell counting, a minimum of 100 cells that were positive for both GFP and the marker in question were counted from a minimum of three separate electroporation experiments.
Coimmunoprecipitation, Western Blotting, and In Vitro SUMOylation Assays In vitro co-IP assays were performed using in vitro transcribed/translated recombinant proteins with or without 35 S-labeling. Recombinant PIAS3, CRX, and NR2E3 proteins were made from the corresponding pcDNA3.1/HisC Figure 7 . Model for Action of Pias3 in Photoreceptor Differentiation ''S'' indicates SUMOylated proteins, while ''X'' indicates an unidentified SUMOylated factor present on the promoters of rod-specific genes. Pias3 in rods binds and SUMOylates Nr2e3 to repress expression of S-cone-specific genes and simultaneously activates expression of rodspecific genes via a SUMOylation-dependent mechanism. Since Pias3-dependent activation of rod-specific genes does not require SUMOylation of Nr2e3 (see Figure S2 ), Pias3 must SUMOylate other transcription factors on rod-specific promoters (shown here as X).
mammalian expression vectors using TnT T7 Quick Coupled Transcription/ Translation Kit (Promega). Co-IPs were performed as described previously (La Spada et al., 2001 ) with minor modifications in the wash buffer (50 mM Tris-Cl [pH 7.4], 150$400 mM NaCl, and 0.5% Triton X-100) and antibodies described in Table S2 . In vivo co-IP assays were performed using retinal nuclear extracts made from P10 wild-type or mutant mice as described previously (Peng and Chen, 2007) , with antibodies used detailed in Table S2 . The results were detected and visualized using the Millipore Western Blotting Detection System (Millipore, Billerica, MA) and Amersham Hyperfilm (GE Healthcare). Cell based co-IP and SUMOylation assays were performed as described in Supplemental Experimental Procedures section.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation has performed as described (Peng et al., 2005) . The results of ChIP assays were analyzed using candidate gene-based PCR with primers spanning the promoter region of each gene (listed in Peng et al. [2005] ). Results shown are representative of at least three separate experiments. Controls include the use of normal rabbit/mouse IgG (Santa Cruz) in immunoprecipitation reactions (negative controls) and input (without IP) as positive controls in PCR reactions. Double chromatin immunoprecipitation assays (double ChIP) were performed using a modification of a previously described protocol (Geisberg and Struhl, 2004) . Details are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, six figures, and two tables and can be found with this article online at http:// www.neuron.org/supplemental/S0896-6273(08)01054-4.
